50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,640.47 (-2.11%)
DOW   29,225.61 (-1.54%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
S&P 500   3,640.47 (-2.11%)
DOW   29,225.61 (-1.54%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
S&P 500   3,640.47 (-2.11%)
DOW   29,225.61 (-1.54%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
S&P 500   3,640.47 (-2.11%)
DOW   29,225.61 (-1.54%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
NASDAQ:EDAP

Edap Tms - EDAP Stock Forecast, Price & News

$8.05
-0.06 (-0.74%)
(As of 09/29/2022 04:13 PM ET)
Add
Compare
Today's Range
$7.84
$8.15
50-Day Range
$7.00
$8.94
52-Week Range
$5.00
$8.99
Volume
31,020 shs
Average Volume
67,042 shs
Market Capitalization
$269.40 million
P/E Ratio
115.00
Dividend Yield
N/A
Price Target
$10.67

Edap Tms MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
32.3% Upside
$10.67 Price Target
Short Interest
Healthy
0.30% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.91mentions of Edap Tms in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From $0.01 to ($0.05) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Medical Sector

434th out of 1,096 stocks

Electromedical Equipment Industry

5th out of 23 stocks

EDAP stock logo

About Edap Tms (NASDAQ:EDAP) Stock

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Receive EDAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edap Tms and its competitors with MarketBeat's FREE daily newsletter.

EDAP Stock News Headlines

Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
EDAP TMS S.A. (EDAP)
EDAP TMS ADSs Drop 13% After Public Offering Prices
Why EDAP Shares Are Falling Sharply
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast
He predicted the 2020 crash a month before it happened…He predicted this year’s collapse back in January… And now, he’s issuing a brand-new warning – along with a unique solution.
EDAP TMS S.A. (EDAP) Q2 2022 Earnings Call Transcript
EDAP Reports Second Quarter 2022 Results
6EDAP : Earnings Preview For Edap TMS
EDAP TMS S.A. Q2 2022 Earnings Preview
See More Headlines
Receive EDAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edap Tms and its competitors with MarketBeat's FREE daily newsletter.

EDAP Company Calendar

Last Earnings
11/17/2021
Today
9/29/2022
Next Earnings (Estimated)
11/16/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EDAP
Employees
223
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$10.67
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+32.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$830,000.00
Pretax Margin
5.26%

Debt

Sales & Book Value

Annual Sales
$51.94 million
Cash Flow
$0.09 per share
Book Value
$1.77 per share

Miscellaneous

Free Float
33,389,000
Market Cap
$269.40 million
Optionable
Optionable
Beta
1.24

Social Links


Key Executives

  • Mr. Marc Oczachowski (Age 52)
    Exec. Chairman & CEO
  • Mr. Francois Dietsch (Age 46)
    Chief Financial Officer
  • Mr. Frederic Pech
    Chief Operating Officer
  • Ms. Blandine Confort
    Investor Relations Officer & Sec.
  • Mr. Frank Van Hyfte
    VP of Global Sales & Marketing













EDAP Stock - Frequently Asked Questions

Should I buy or sell Edap Tms stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" EDAP shares.
View EDAP analyst ratings
or view top-rated stocks.

What is Edap Tms' stock price forecast for 2022?

2 analysts have issued 1 year price targets for Edap Tms' stock. Their EDAP share price forecasts range from $10.00 to $11.00. On average, they anticipate the company's share price to reach $10.67 in the next year. This suggests a possible upside of 31.4% from the stock's current price.
View analysts price targets for EDAP
or view top-rated stocks among Wall Street analysts.

How have EDAP shares performed in 2022?

Edap Tms' stock was trading at $5.99 at the start of the year. Since then, EDAP stock has increased by 35.5% and is now trading at $8.1150.
View the best growth stocks for 2022 here
.

When is Edap Tms' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 16th 2022.
View our EDAP earnings forecast
.

How were Edap Tms' earnings last quarter?

Edap Tms S.A. (NASDAQ:EDAP) announced its quarterly earnings data on Wednesday, November, 17th. The medical equipment provider reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.02. The medical equipment provider earned $11.09 million during the quarter, compared to analysts' expectations of $12.53 million. Edap Tms had a trailing twelve-month return on equity of 4.77% and a net margin of 4.77%. During the same quarter last year, the firm posted ($0.04) earnings per share.

What other stocks do shareholders of Edap Tms own?
What is Edap Tms' stock symbol?

Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."

How do I buy shares of Edap Tms?

Shares of EDAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Edap Tms' stock price today?

One share of EDAP stock can currently be purchased for approximately $8.12.

How much money does Edap Tms make?

Edap Tms (NASDAQ:EDAP) has a market capitalization of $271.61 million and generates $51.94 million in revenue each year. The medical equipment provider earns $830,000.00 in net income (profit) each year or $0.07 on an earnings per share basis.

How many employees does Edap Tms have?

The company employs 223 workers across the globe.

How can I contact Edap Tms?

Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The official website for the company is www.edap-tms.com. The medical equipment provider can be reached via phone at (347) 215-3150, via email at bconfort@edap-tms.com, or via fax at 33-04-72-15-31-51.

This page (NASDAQ:EDAP) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.